Clinical trial
A Study to EvaLuate the EffIcacy and Safety of XyloCore, a Glucose SparIng ExpeRimental Solution, for Peritoneal Dialysis
NCT03994471 is registered in ClinicalTrials.gov with Iperboreal Pharma Srl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to EvaLuate the EffIcacy and Safety of XyloCore, a Glucose SparIng ExpeRimental Solution, for Peritoneal Dialysis
- Lead sponsor
- Iperboreal Pharma Srl
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- December 14, 2022
- Completion date
- April 28, 2027
- Enrollment
- 170 (estimated)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease